Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers
BackgroundThe immune response to hepatitis B vaccine may be influenced by numerous factors, and patients with non/low response re-exposed to hepatitis B virus remain susceptible. Thus, a better understanding of the underlying mechanisms of non/low immune response in infants born to Hepatitis B surfa...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2024.1332666/full |
_version_ | 1797289722235584512 |
---|---|
author | Guanyong Ou Guanyong Ou Ling Qing Ling Qing Li Zhang Li Zhang Yang Yang Guoguo Ye Ling Peng Yanjie Li Liuqing Yang Yingxia Liu |
author_facet | Guanyong Ou Guanyong Ou Ling Qing Ling Qing Li Zhang Li Zhang Yang Yang Guoguo Ye Ling Peng Yanjie Li Liuqing Yang Yingxia Liu |
author_sort | Guanyong Ou |
collection | DOAJ |
description | BackgroundThe immune response to hepatitis B vaccine may be influenced by numerous factors, and patients with non/low response re-exposed to hepatitis B virus remain susceptible. Thus, a better understanding of the underlying mechanisms of non/low immune response in infants born to Hepatitis B surface antigen (HBsAg)-positive mothers is essential.Methods100 infants born to HBsAg-positive mothers from 2015 to 2020 were enrolled in the study, further divided into the non/low response group (n=13) and the moderate strong response group (n=87) based on the quantification of hepatitis B surface antibody at 12 months of age. The differential expression of 48 immune-related cytokines in the two groups was compared and analyzed in detail. The key cytokines were further identified and clinically predictive models were developed.ResultsWe found that 13 cytokines were lowly expressed and one cytokine was highly expressed in the non/low response group, compared with the moderate strong response group at birth. In addition, 9 cytokines were lowly expressed and one cytokine was highly expressed in the non/low response group at 12 months of age. Furthermore, we found that IL-5 and HGF were promising predictors for predicting the immunization response to hepatitis B vaccine in infants, and the combination of the two cytokines showed the best predictive efficiency, with an area under the curve (AUC) value of 0.844.ConclusionThe present study provides a theoretical basis on cytokines for developing and implementing effective immunotherapies against non/low immune response in infants born to HBsAg-positive mothers. |
first_indexed | 2024-03-07T19:10:07Z |
format | Article |
id | doaj.art-29d3676485e44441b7c6c53b0652a7d7 |
institution | Directory Open Access Journal |
issn | 2235-2988 |
language | English |
last_indexed | 2024-03-07T19:10:07Z |
publishDate | 2024-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cellular and Infection Microbiology |
spelling | doaj.art-29d3676485e44441b7c6c53b0652a7d72024-03-01T04:55:15ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882024-03-011410.3389/fcimb.2024.13326661332666Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothersGuanyong Ou0Guanyong Ou1Ling Qing2Ling Qing3Li Zhang4Li Zhang5Yang Yang6Guoguo Ye7Ling Peng8Yanjie Li9Liuqing Yang10Yingxia Liu11National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSchool of Medicine, Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaGraduate Collaborative Training Base of Shenzhen Third People’s Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaGraduate Collaborative Training Base of Shenzhen Third People’s Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaBackgroundThe immune response to hepatitis B vaccine may be influenced by numerous factors, and patients with non/low response re-exposed to hepatitis B virus remain susceptible. Thus, a better understanding of the underlying mechanisms of non/low immune response in infants born to Hepatitis B surface antigen (HBsAg)-positive mothers is essential.Methods100 infants born to HBsAg-positive mothers from 2015 to 2020 were enrolled in the study, further divided into the non/low response group (n=13) and the moderate strong response group (n=87) based on the quantification of hepatitis B surface antibody at 12 months of age. The differential expression of 48 immune-related cytokines in the two groups was compared and analyzed in detail. The key cytokines were further identified and clinically predictive models were developed.ResultsWe found that 13 cytokines were lowly expressed and one cytokine was highly expressed in the non/low response group, compared with the moderate strong response group at birth. In addition, 9 cytokines were lowly expressed and one cytokine was highly expressed in the non/low response group at 12 months of age. Furthermore, we found that IL-5 and HGF were promising predictors for predicting the immunization response to hepatitis B vaccine in infants, and the combination of the two cytokines showed the best predictive efficiency, with an area under the curve (AUC) value of 0.844.ConclusionThe present study provides a theoretical basis on cytokines for developing and implementing effective immunotherapies against non/low immune response in infants born to HBsAg-positive mothers.https://www.frontiersin.org/articles/10.3389/fcimb.2024.1332666/fullhepatitis B vaccineimmune responseinfantcytokineIL-5HGF |
spellingShingle | Guanyong Ou Guanyong Ou Ling Qing Ling Qing Li Zhang Li Zhang Yang Yang Guoguo Ye Ling Peng Yanjie Li Liuqing Yang Yingxia Liu Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers Frontiers in Cellular and Infection Microbiology hepatitis B vaccine immune response infant cytokine IL-5 HGF |
title | Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers |
title_full | Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers |
title_fullStr | Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers |
title_full_unstemmed | Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers |
title_short | Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers |
title_sort | cytokine il 5 and hgf combined prediction of non low immune response to hepatitis b vaccination at birth in infants born to hbsag positive mothers |
topic | hepatitis B vaccine immune response infant cytokine IL-5 HGF |
url | https://www.frontiersin.org/articles/10.3389/fcimb.2024.1332666/full |
work_keys_str_mv | AT guanyongou cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT guanyongou cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT lingqing cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT lingqing cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT lizhang cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT lizhang cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT yangyang cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT guoguoye cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT lingpeng cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT yanjieli cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT liuqingyang cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers AT yingxialiu cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers |